Genetics Generation Advancement Corp. (TPEX:4160)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
43.50
+0.40 (0.93%)
Apr 29, 2026, 1:30 PM CST
-22.04%
Market Cap 1.15B
Revenue (ttm) 603.11M
Net Income (ttm) 21.37M
Shares Out 26.69M
EPS (ttm) 0.80
PE Ratio 53.88
Forward PE n/a
Dividend 1.85 (4.24%)
Ex-Dividend Date Oct 3, 2025
Volume 39,326
Average Volume 43,533
Open 43.50
Previous Close 43.10
Day's Range 43.10 - 43.65
52-Week Range 43.00 - 60.50
Beta 0.49
RSI 37.65
Earnings Date May 14, 2026

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and... [Read more]

Sector Healthcare
Founded 2008
Employees 104
Stock Exchange Taipei Exchange
Ticker Symbol 4160
Full Company Profile

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.

Financial Statements

News

There is no news available yet.